1. Breaking News: Celgene Stockholders Approve Proposed Acquisition by Bristol-Myers Squibb

    Breaking News:  Celgene Stockholders Approve Proposed Acquisition by Bristol-Myers Squibb

    SUMMIT, N.J.--(BUSINESS WIRE)--Apr 12, 2019--Celgene Corporation (NASDAQ: CELG) today announced that its stockholders have voted to approve the company’s proposed combination with Bristol-Myers Squibb Company (NYSE: BMY). Approximately 98% of the votes cast, and over 70% of the shares outstanding and entitled to vote, voted in favor of the transaction at the special meeting...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Topics Mentioned